Do Anxiety and Depression Levels Affect the Inflammation Response in Patients Hospitalized for COVID-19
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The whole world is still struggling with the COVID-19 pandemic. Inflammation response, thought to be associated with severe illness and death, is an important research topic in COVID-19. Inflammation is also an essential condition explored in psychiatric illnesses. Our knowledge about the relationship between the inflammation response and psychiatric comorbidities in patients with COVID-19 is very limited. In this study, the relationship between anxiety and depression levels and inflammation response of patients with COVID-19 hospitalized in the hospital was examined.Methods 175 patients were included in the study. Sociodemographic Data Form, Beck Depression Inventory and Beck Anxiety Inventory were applied to the patients. To evaluate the inflammation responses, blood sedimentation rate, C-reactive protein (CRP), procalcitonin, ferritin, neutrophil/lymphocyte ratio (NLR), and IL-6 levels were examined.Results In our study, no relationship was found between anxiety and depression levels and inflammatory responses in patients hospitalized with a diagnosis of COVID-19. Anxiety and depression levels of women were higher than men, and NLR, ferritin, IL-6 levels were found to be lower than men. Anxiety levels increase with age. There is a positive correlation between NLR and ferritin levels and duration of hospitalization.Conclusion Our study examining the relationship of psychiatric comorbidities with the inflammation response and our increasing literature knowledge, together with studies evaluating the mental effects of COVID-19, suggest that determining the relationship between inflammation responses and psychiatric comorbidities in COVID-19, whose pathophysiology has not been clarified yet, maybe an essential step in interventions on the course of the disease.
Abstract
Objective The whole world is still struggling with the COVID-19 pandemic. Inflammation response, thought to be associated with severe illness and death, is an important research topic in COVID-19. Inflammation is also an essential condition explored in psychiatric illnesses. Our knowledge about the relationship between the inflammation response and psychiatric comorbidities in patients with COVID-19 is very limited. In this study, the relationship between anxiety and depression levels and inflammation response of patients with COVID-19 hospitalized in the hospital was examined.Methods 175 patients were included in the study. Sociodemographic Data Form, Beck Depression Inventory and Beck Anxiety Inventory were applied to the patients. To evaluate the inflammation responses, blood sedimentation rate, C-reactive protein (CRP), procalcitonin, ferritin, neutrophil/lymphocyte ratio (NLR), and IL-6 levels were examined.Results In our study, no relationship was found between anxiety and depression levels and inflammatory responses in patients hospitalized with a diagnosis of COVID-19. Anxiety and depression levels of women were higher than men, and NLR, ferritin, IL-6 levels were found to be lower than men. Anxiety levels increase with age. There is a positive correlation between NLR and ferritin levels and duration of hospitalization.Conclusion Our study examining the relationship of psychiatric comorbidities with the inflammation response and our increasing literature knowledge, together with studies evaluating the mental effects of COVID-19, suggest that determining the relationship between inflammation responses and psychiatric comorbidities in COVID-19, whose pathophysiology has not been clarified yet, maybe an essential step in interventions on the course of the disease.
참고문헌 (52)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study", Lancet, 395, pp.507~513 (2020)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- Hadjadj J, "Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients", MedRxiv;, ~ (2020)
- Mehta P, "COVID-19 : consider cytokine storm syndromes and immunosuppression", Lancet, 395, pp.1033~1034 (2020)
- Xu Z, "Pathological findings of COVID-19 associated with acute respiratory distress syndrome", Lancet Respir Med, 8, pp.420~422 (2020)
- Feng Z, "The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)directly decimates human spleens and lymph nodes", MedRxiv, ~ (2020)
- Diao B, "Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection", MedRxiv, ~ (2020)
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Chen G, "Clinical and immunological features of severe and moderate coronavirus disease 2019", J Clin Invest, 130, pp.2620~2629 (2020)
- Gong J, "Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia", MedRxiv, ~ (2020)
- McGonagle D, "The Role of Cytokines including Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome-like disease", Autoimmun Rev, 19, pp.102537~ (2020)
- Xu X, "Effective treatment of severe COVID-19 patients with tocilizumab", Proc Natl Acad Sci U S A, 117, pp.10970~10975 (2020)
- Gritti G, "Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support", MedRxiv, ~ (2020)
- Dantzer R, "From inflammation to sickness and depression : when the immune system subjugates the brain", Nat Rev Neurosci, 9, pp.46~56 (2008)
- O’Connor TG, "Annual research review : the neuroinflammation hypothesis for stress and psychopathology in children–developmental psychoneuroimmunology", J Child Psychol Psychiatry, 55, pp.615~631 (2014)
- Valkanova V, "CRP, IL-6 and depression : a systematic review and meta-analysis of longitudinal studies", J Affect Disord, 150, pp.736~744 (2013)
- Capuron L, "Immune system to brain signaling : neuropsychopharmacological implications", Pharmacol Ther, 130, pp.226~238 (2011)
- Demir S, "Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy", Neuropsychiatr Dis Treat, 11, pp.2253~2258 (2015)
- Özyurt G, "The neutrophil-lymphocyte ratio and plateletlymphocyte ratio in adolescent obsessive-compulsive disorder: does comorbid anxiety disorder affect inflammatory response?", Psychiatry Res, 272, pp.311~315 (2019)
- Karlović D, "Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features", Psychiatry Res, 198, pp.74~80 (2012)
- Kiecolt-Glaser JK, "Chronic stress and age-related increases in the proinflammatory cytokine IL-6", Proc Natl Acad Sci U S A, 100, pp.9090~9095 (2003)
- Wiedemann K, "Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour", Exp Clin Endocrinol Diabetes, 108, pp.5~13 (2000)
- Dai LL, "Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China", PLos One, 15, pp.e0238416~ (2020)
- Zhang J, "The relationship between resilience, anxiety, and depression among patients with mild symptoms of COVID-19 in China : a cross-sectional study", J Clin Nurs, 29, pp.4020~4029 (2020)
- Sun YJ, "Clinical features of fatalities in patients with COVID-19", Disaster Med Public Health Prep, pp.1~3 (2020)
- Mazza MG, "Anxiety and depression in COVID-19 survivors : role of inflammatory and clinical predictors", Brain Behav Immun, 89, pp.594~600 (2020)
- Beck AT, "Beck depression inventory(BDI)", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Hisli N, "Beck Depresyon Ölçeği’nin bir Türk örnekleminde geçerlilik ve güvenilirliği", Psikoloji Dergisi, 6, pp.118~122 (1988)
- Beck AT, "An inventory for measuring clinical anxiety : psychometric properties", J Consult Clin Psychol, 56, pp.893~897 (1988)
- Ulusoy M, "The Beck anxiety inventory : psychometric properties", J Cogn Psychother, 12, pp.163~172 (1998)
- Parsons C, "Inflammation and anxiety‐based disorders in children and adolescents–a systematic review and meta‐analysis", Child Adolesc Ment Health (2020)
- Howren MB, "Associations of depression with Creactive protein, IL-1, and IL-6 : a meta-analysis", Psychosom Med, 71, pp.171~186 (2009)
- O’Donovan A, "Clinical anxiety, cortisol and interleukin-6 : evidence for specificity in emotion–biology relationships", Brain Behav Immun, 24, pp.1074~1077 (2010)
- Lamers F, "Longitudinal association between depression and inflammatory markers : results from the Netherlands study of depression and anxiety", Biol Psychiatry, 85, pp.829~837 (2019)
- Saini KS, "Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy", Br J Cancer, 123, pp.694~697 (2020)
- Dorfman HM, "Neuroscience of Aggression", pp.297~313 (2013), Springer
- Mazza MG, "Neutrophil", lymphocyte ratio and platelet, Prog Neuropsychopharmacol Biol Psychiatry, pp.2018, 84[DOI]
- Esra Aydin Sunbul, "Increased Neutrophil", Lymphocyte Ratio in Patients with Depression is Correlated with the Severity of Depression and Cardiovascular Risk Factors, 2016, pp.13(1), 121~126[DOI]
- Brinn A, "Neutrophil–lymphocyte ratio across psychiatric diagnoses : a cross-sectional study using electronic health records", BMJ Open, 10, pp.e036859~ (2020)
- Zulfic Z, "Neutrophil–lymphocyte ratio–a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders?", Australas Psychiatry, 28, pp.454~458 (2020)
- Hacimusalar Y, "Anxiety and hopelessness levels in COVID-19 pandemic : a comparative study of healthcare professionals and other community sample in Turkey", J Psychiatr Res, 129, pp.181~188 (2020)
- Özdin S, "Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society : the importance of gender", Int J Soc Psychiatry, 66, pp.504~511 (2020)
- Pierce M, "Mental health before and during the COVID-19 pandemic : a longitudinal probability sample survey of the UK population", Lancet Psychiatry, 7, pp.883~892 (2020)
- Brooks SK, "Rapid Review", Lancet, 395, pp.912~920 (2020)
- Liu S, "Prevalence and patterns of tobacco smoking among Chinese adult men and women : findings of the 2010 national smoking survey", J Epidemiol Community Health, 71, pp.154~161 (2017)
- Zeng Z, "Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China", Crit Care, 24, pp.525~ (2020)
- Klein SL, "Sex differences in immune responses", Nat Review Immunol, 16, pp.626~638 (2016)
- Meng Y, "Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China : a retrospective study of 168 severe patients", PLoS Pathog, 16, pp.e1008520~ (2020)
- Kadel S, "Sex hormones regulate innate immune cells and promote sex differences in respiratory virus infection", Front Immunol, 9, pp.1653~ (2018)
- Tezcan ME, "Laboratory abnormalities related to prolonged hospitalization in COVID-19", Infect Dis(Lond), 52, pp.666~668 (2020)
- Lin Z, "Serum ferritin as an independent risk factor for severity in COVID-19 patients", J Infect(Lond), 81, pp.647~679 (2020)
- Gottlieb M, "Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, Illinois", Acad Emerg Med, 27, pp.963~973 (2020)